Historique
Rapport
WHO expert committee on drug dependence. 36th report
Auteur(s) :
OMS / WHO (Organisation mondiale de la santé / World Health Organization)
Année
2015
Page(s) :
52 p.
Langue(s) :
Anglais
Éditeur(s) :
Genève : OMS / WHO
Collection :
Rapports techniques / Technical report series, n°991
ISBN :
978-92-4-120991-5
Refs biblio. :
10
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus mots-clés
METHOXETAMINE
;
RECOMMANDATION
;
CONTROLE DES STUPEFIANTS
;
DROIT INTERNATIONAL
;
DROGUES DE SYNTHESE
;
GHB
;
KETAMINE
;
TRAITE INTERNATIONAL
;
PIPERAZINES
;
mCPP
;
GBL
;
BZP
;
PHARMACOVIGILANCE
;
POTENTIEL ADDICTIF
;
EVALUATION
;
MEPHEDRONE
Thésaurus géographique
INTERNATIONAL
Résumé :
This report presents the recommendations of the thirty-sixth WHO Expert Committee on Drug Dependence (ECDD). The ECDD is responsible for the assessment of therapeutic usefulness, the liability to abuse and dependence and the public health and social harm of each substance under review. After receiving the advice from the Expert Committee to schedule or to amend the scheduling status of a substance, the Director-General of WHO will as appropriate, communicate the recommendations to the United Nations. The report summarizes the review of 26 substances and the Committee's recommendations for scheduling under the international drug control conventions. The report also contains updates from international bodies concerned with controlled substances, a summary of the follow-up on recommendations made at the previous Committee meeting and a summary of the discussion on improving data collection and evidence for prioritization and substance evaluation, in particular for new psychoactive substances. Issues identified for consideration at future Expert Committee meetings are also listed.
Autre(s) lien(s) :
3,4-Methylenedioxypyrovalerone (MDPV). Critical review report